alphaveALPA₹62.19

Alpa Laboratories Limited

₹ CrorePeersBALPHARMA KREBSBIO NATCAPSUQ VINEETLAB NECLIFE AAREYDRUGS BIOFILCHEM MANGALAMMcap ₹131 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	11.4	20.6	20.1	20.1
+ Other Intangibles	0.0	0.0	0.0	0.0
+ Intangibles under Development	0.1	0.0	0.0	0.0
+ Non-current Investments	6.9	7.4	6.6	6.6
+ Other Non-current Financial Assets	3.0	3.4	4.5	4.5
Non-current Financial Assets	9.9	10.8	11.1	11.1
Total Non-current Assets	21.4	31.4	31.2	31.2
Current Assets
+ Inventories	13.7	17.6	13.3	13.3
+ Current Investments	91.1	110.5	135.0	135.0
+ Trade Receivables	41.4	46.8	40.8	40.8
+ Cash & Cash Equivalents	0.1	0.0	0.6	0.6
+ Other Bank Balances	1.6	2.2	2.2	2.2
+ Short-term Loans	0.6	0.5	0.5	0.5
+ Other Current Financial Assets	1.8	1.3	2.9	2.9
Current Financial Assets	136.7	161.3	182.2	182.2
+ Other Current Assets	9.0	8.9	12.5	12.5
Total Current Assets	161.2	191.2	210.9	210.9
Total Assets	182.6	222.6	242.1	242.1
Equity
+ Equity Share Capital	21.0	21.0	21.0	21.0
+ Other Equity / Reserves	130.9	150.4	165.2	165.2
Equity — Owners of Parent	151.9	171.4	186.3	186.3
Total Equity	151.9	171.4	186.3	186.3
Liabilities
+ Deferred Tax Liabilities	2.4	4.5	3.3	3.3
Non-current Liabilities	2.4	4.5	3.3	3.3
+ Borrowings — Current	5.2	0.0	2.5	2.5
+ Trade Payables	11.8	18.7	17.8	17.8
+ Other Current Financial Liab	1.1	1.1	1.3	1.3
Current Financial Liabilities	18.1	19.7	21.6	21.6
+ Provisions — Current	2.4	5.6	6.4	6.4
+ Other Current Liabilities	7.8	21.4	24.5	24.5
Current Liabilities	28.3	46.7	52.5	52.5
Total Liabilities	30.7	51.2	55.9	55.9
Total Equity & Liabilities	182.6	222.6	242.1	242.1
Assets — additional as-filed lines
+ Current Tax Assets	1.9	3.3	2.9	2.9
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	1.5	4.3	4.3
+ Dues to Other Creditors — Current	—	17.2	13.5	13.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.